Control of systemic capillary leak syndrome with aminophylline and terbutaline.

[1]  B. Johansson,et al.  Systemic capillary leak syndrome with monoclonal IgG and complement alterations. A case report on an episodic syndrome. , 2009, Acta medica Scandinavica.

[2]  Erik Svensjö,et al.  Quantitative physiological and morphological aspects of microvascular permeability changes induced by histamine and inhibited by terbutaline. , 1982, Acta physiologica Scandinavica.

[3]  M. Bens,et al.  Production of 5‐lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease) , 1987, European journal of clinical investigation.

[4]  A. Rosti,et al.  The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. , 1990, Annals of internal medicine.

[5]  P. Padfield,et al.  SYSTEMIC CAPILLARY LEAK SYNDROME , 1989, The Lancet.

[6]  J. Madrenas,et al.  Anterior tibial compartment syndrome secondary to systemic capillary leak syndrome. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[7]  A. Laufer,et al.  Electron microscopical studies of the effect of antiheart antibodies and complement on beating heart cells in culture. , 1976, Journal of molecular and cellular cardiology.

[8]  A. Morice,et al.  TREATMENT OF SYSTEMIC CAPILLARY LEAK SYNDROME , 1988, The Lancet.

[9]  K. Rahbar,et al.  [Recurrent shock with monoclonal gammopathy. Treatment in the acute and chronic phases with oral and parenteral Ginkgo biloba extract]. , 1986, Presse medicale.

[10]  L. Bergamaschini,et al.  Systemic capillary leak syndrome. Evaluation of single protein fractions in serum and in interstitial fluid. , 1979, Bibliotheca anatomica.

[11]  B. Clarkson,et al.  Cyclical edema and shock due to increased capillary permeability. , 1960, Transactions of the Association of American Physicians.

[12]  R. Morgan.  Letter: Closure of St. Wulstan's hospital. , 1975, Lancet.

[13]  B. Johansson,et al.  Ultrastructure of the microvessels in skeletal muscle in a case of systemic capillary leak syndrome. , 2009, Acta medica Scandinavica.

[14]  T. Waldmann,et al.  SYSTEMIC CAPILLARY LEAK SYNDROME AND MONOCLONAL IgG GAMMOPATHY: Studies in a Sixth Patient and a Review of the Literature , 1977, Medicine.

[15]  P. Ferrier.  [Fetal alcohol syndrome]. , 1973, Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften.

[16]  Edwards Jh.  Letter: Testing for Tay-Sachs heterozygotes. , 1973 .

[17]  J. Hagstrom,et al.  Hypovolemic shock and edema due to increased capillary permeability. , 1967, JAMA.

[18]  A. Larcan,et al.  Cyclical shock with hyperglobulinemia. , 1975, Bibliotheca anatomica.

[19]  R. Jacox,et al.  Periodic disease associated with muscle destruction. , 1973, The American journal of medicine.

[20]  I. Weinbren.  SPONTANEOUS PERIODIC ŒDEMA: A New Syndrome , 1963 .

[21]  P. Toghill,et al.  EPOPROSTENOL IN SYSTEMIC CAPILLARY LEAK SYNDROME , 1988, The Lancet.

[22]  A. Larcan,et al.  [Cyclic shock due to increased capillary permeability. Probable role of immunoglobulin G]. , 1969, La Presse medicale.

[23]  R. Valentijn,et al.  Systemic capillary leak syndrome. Preventive treatment with terbutaline. , 1988, The Netherlands journal of medicine.

[24]  A. Larcan,et al.  Choc cyclique par exagération de la perméabilité capillaire. Responsabilité probable d'une immunoglobuline G. , 1969 .

[25]  G. Lagrue,et al.  Choc récidivant avec gammapathie monoclonale. Traitement en phase aiguë et chronique par l'extrait de Ginkgo biloba oral et parentéral. , 1986 .